Hollywood Movies Rarely Reflect Climate Change Crisis. These Researchers Want to Change That

This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)
This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)
TT

Hollywood Movies Rarely Reflect Climate Change Crisis. These Researchers Want to Change That

This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)
This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)

Aquaman might not mind if the oceans rise, but moviegoers might.

That's one of the takeaways from a new study conducted by researchers who set out to determine if today's Hollywood blockbusters are reflective of the current climate crisis. The vast majority of movies failed the “climate reality check” proposed by the authors, who surveyed 250 movies from 2013 to 2022.

The test is simple — the authors looked to see if a movie presented a story in which climate change exists, and whether a character knows it does. One film that passed the test was the 2017 superhero movie Justice League, in which Jason Momoa's Aquaman character says, “Hey, I don't mind if the oceans rise” to Ben Affleck's Bruce Wayne, The AP reported.

But most movies fell short — fewer than 10% of the 250 films passed, and climate change was mentioned in two or more scenes of fewer than 4% of the films. That's out of touch with a moviegoing public that wants “to see their reality reflected on screen,” said Colby College English professor Matthew Schneider-Mayerson, lead researcher on the study.

“The top line is just that the vast majority of films, popular films produced over the last 10 years in the United States, are not portraying the world as it is,” Schneider-Mayerson said. “They are portraying a world that is now history or fantasy — a world in which climate change is not happening.”

Researchers at Maine's Colby College published the study in April along with Good Energy, a Los Angeles-based environmental consultancy. The results were peer reviewed, and the authors are seeking publication in scientific journals. The researchers view the test as a way for audience members, writers and filmmakers to evaluate the representation of climate change on screen.

Some results were surprising. Movies that at first glance appear to have little overlap with climate or the environment passed the test. Marriage Story, Noah Baumbach's emotive 2019 drama about the collapse of a relationship, passed the test in part because Adam Driver's character is described as “energy conscious,” Schneider-Mayerson said.

The 2022 whodunnit Glass Onion and the 2019 folk horror movie Midsommar were others to pass the test. Some that were more explicitly about climate change, such as the 2021 satire Don't Look Up, also passed. But San Andreas, a 2015 movie about a West Coast earthquake disaster, and The Meg, a 2018 action movie set in the ocean, did not.

The authors narrowed the selection of movies by excluding films not set on Earth or set before 2006 or after 2100. They found streaming services had a higher percentage of movies that included climate change than the major studios did.

The study is “valuable for marketing purposes, informational purposes, data accumulation,” said Harry Winer, director of sustainability at the Kanbar Institute of Film and Television at the New York University Tisch School of the Arts. Winer, who was not involved in the study, said it could also help serve as an incentive to connect audiences with climate stories.

“The audience will be more open to hearing a dialogue about what is right and what is wrong,” Winer said. “It's a conversation starter.”

The study authors said they see the climate reality check as a kind of Bechdel-Wallace test for climate change. Alison Bechdel, a cartoonist, is credited with popularizing that test in the 1980s by incorporating her friend Liz Wallace's test about gender representation in film into a comic strip. The test asks if a movie includes at least two female characters who have a conversation about something other than a man.

Bechdel herself spoke highly of the study's climate test, which she described as “long overdue” in a social media post during this year's Academy Awards season. Bechdel said in an e-mail to The AP that “for a movie set in the present to ignore this existential threat just doesn't make sense anymore" in the age of climate change.

“I do worry that screenwriters might do it in a kind of rote way, which could be counterproductive, just like rote ‘strong female characters’ are," Bechdel said. "But injecting an awareness of our communal plight into the stories we ingest seems like a no-brainer.”



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”